Introduction We focused on the stable gastric pentadecapeptide BPC 157 ( Thus, we suggest that one single application of the NO-synthase (NOS) blocker N(G)-nitro-L-arginine methyl ester (L-NAME) may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application (see In the previous eye research studies, BPC 157 counteracts atropine-mydriasis, but it also opposes an immediate and hour-lasting miotic effect of L-NAME in rats and guinea pigs, and participates in pupil control potentially via NO-mediated and cholinergic mechanisms ( This may be essential for the effective counteraction of the damaging effect of the retrobulbar L-NAME application
Extracellular NM released by dying dopaminergic neurons plays a critical role in triggering chronic neuroinflammation in PD
Functional impact of risk gene variants on the autoimmune responses in type 1 diabetes
With regular use, your skin looks brighter, hydrated, and visibly refreshed
Effect of a commercially-available algal phlorotannins extract on digestive enzymes and carbohydrate absorption in vivo
The guide to finding peptide therapy providers and the online peptide therapy options can help connect individuals with qualified practitioners
